Junhua Ai
Papers
4
Total Citations
189
H-Index
4
About
Dr. Junhua Ai is a leading surgical oncologist whose research focuses on advancing minimally invasive treatments for gastrointestinal cancers, particularly rectal and gastric cancer. Dr. Ai’s major contributions lie in systematically evaluating the comparative effectiveness and safety of robotic versus laparoscopic surgery. Their landmark 2021 meta-analysis, cited over 100 times, provided critical evidence that robotic rectal cancer surgery may offer advantages over the laparoscopic approach, helping to resolve a long-standing clinical debate. Dr. Ai further demonstrated the long-term oncological safety of robotic mesorectal excision in a highly cited 2020 systematic review, and extended this analysis to gastric cancer surgery in 2019. Notably, their prospective cohort study on male urogenital function after rectal cancer surgery is a vital contribution to improving patient quality of life, a frequently overlooked outcome. Through rigorous meta-analyses and prospective research, Dr. Ai has produced a body of work with over 189 citations, establishing them as a key voice in the evidence-based evolution of robotic surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4